Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

NEW

Research Center
Additional Locations Alabama

Genfit is conducting the RESOLVE-IT Study, a Phase III clinical research study evaluating the investigational medication elafibranor vs. placebo for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis (scar tissue). The RESOLVE-IT Study is currently looking for qualified participants.

NASH is a progressive liver disease characterized by a buildup of fat in the liver (steatosis), as well as inflammation and degeneration of liver cells.

RESEARCH STUDY TITLE

The RESOLVE-IT Research Study Is A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.

Research Site
Birmingham Alabama 35233

Does type 2 diabetes run in your family? Then sit up and take notice

NEW

Research Center
Fort Payne Alabama 35967

FIDELIO-DKD & FIGARO-DKD – For Patients with Type 2 Diabetes

Research Site
Huntsville Alabama

A Phase 3 clinical study of Ertugliflozin for patients with Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease who have inadequate glycemic control on metformin

Boehringer Ingelheim Investigational Site
Mobile Alabama 36601

Clinical trial for Diabetes Mellitus, Type 2

View More ▼

UPDATED

Anniston Alabama 36207

A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2

UPDATED

Birmingham Alabama 35205

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama 35233-1711

A clinical research study for the treatment of Type 2 Diabetes Mellitus

UPDATED

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Birmingham Alabama 35211

A clinical trial to evaluate treatments for patients with Type 2 Diabetes Mellitus

UPDATED

Birmingham Alabama 35294-2041

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Birmingham Alabama 35233

A clinical trial to evaluate treatments using liraglutide, placebo and metformin for patients with Diabetes or Diabetes Mellitus, Type 2

Birmingham Alabama 35233-1711

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Birmingham Alabama 35233-1711

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

UPDATED

Birmingham Alabama 35233

A Phase 3 clinical study for patients with Metabolism and Nutrition Disorder or Obesity

Birmingham Alabama

A Phase 3 clinical study for patients with Type 2 Diabetes or Comparative Effectiveness of Glycemia-lowering Medications

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating Bexagliflozin, Placebo for Bexagliflozin, Glimepiride and Placebo for Glimepiride for the treatment of Type 2 Diabetes Mellitus

Birmingham Alabama 35209

Patients are needed to participate in a clinical research study evaluating Ertugliflozin and Placebo for the treatment of Type 2 Diabetes Mellitus

UPDATED

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Birmingham Alabama 35211

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating placebo and exenatide for the treatment of Type 2 Diabetes

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study of Sotagliflozin (SAR439954), Placebo and Metformin to evaluate Type 2 Diabetes Mellitus

UPDATED

Birmingham Alabama 35211

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2

UPDATED

Fort Payne Alabama 35967

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

UPDATED

Fort Payne Alabama 35967

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Gulf Shores Alabama 36542

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Guntersville Alabama 35976

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Haleyville Alabama 35565-1719

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2

UPDATED

Huntsville Alabama 35801-4317

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

UPDATED

Huntsville Alabama

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus

UPDATED

Huntsville Alabama 35801-4317

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

UPDATED

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Montgomery Alabama 36109

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Montgomery Alabama 36104

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

Muscle Shoals Alabama 35662

A clinical trial to evaluate treatments using Evolocumab and Placebo to Evolocumab for patients with Hypercholesterolemia, Mixed Dyslipidemia or Type 2 Diabetes

UPDATED

Saraland Alabama 36571

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

UPDATED

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study to evaluate Diabetes Mellitus, Type 2

UPDATED

Tuscumbia Alabama 35674

A clinical trial to evaluate treatments using semaglutide and placebo for patients with Diabetes or Diabetes Mellitus, Type 2

Tuscumbia Alabama 35674

A Phase 2 clinical study for patients with Type 2 Diabetes Mellitus

UPDATED

Tuscumbia Alabama 35674

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2

Alaska

UPDATED

Little Rock Alaska 72205

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

Arizona

NEW

Research Center
Additional Locations Arizona

Genfit is conducting the RESOLVE-IT Study, a Phase III clinical research study evaluating the investigational medication elafibranor vs. placebo for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis (scar tissue). The RESOLVE-IT Study is currently looking for qualified participants.

NASH is a progressive liver disease characterized by a buildup of fat in the liver (steatosis), as well as inflammation and degeneration of liver cells.

RESEARCH STUDY TITLE

The RESOLVE-IT Research Study Is A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.

Verde Valley Medical Center
Cottonwood Arizona 86326

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

Arrowhead Health Centers
Glendale Arizona 85306

A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.

Phoenix Medical Research
Peoria Arizona 85381

A Phase IIa, Multicenter, Placebo-and Active-controlled, Randomized, Double-Blind, Clinical Trial to Evaluate the Safety and Efficacy of MK-8521 Compared to Placebo in Subjects with Type 2 Diabetes Mellitus

NEW

Research Center
Tucson Arizona 85724

FIDELIO-DKD & FIGARO-DKD – For Patients with Type 2 Diabetes